You don't have credit card details available. You will be redirected to update payment method page. Click OK to continue.
You need to be a full subscriber to access this feature of the Switzer Super Report. Click here to upgrade your subscription or read recently answered questions below
James Dunn is a freelance finance journalist and media consultant. James was founding editor of Shares magazine, and formerly, the personal investment editor at The Australian.
His first book, Share Investing for Dummies, was published by John Wiley & Co. in September 2002: a second edition was published in March 2007...View more >
Here are three Australian stocks in very different industries leveraging into big global market opportunities.
Here are three smaller companies on the ASK that are advancing their device products in a very promising manner and hoping to emulate the examples of Cochlear and ResMed.
Here are three non-Australian ASX-listed software providers whose products are used all over the world.
Like a number of similar companies, Atlassian has huge total addressable markets to grow into, and large material upside possible. Here’s my view on this company listed on the NASDAQ but founded by ..
In my experience over years of writing in this area, every investor is looking for cheap stocks. Today I’ve come up with three that I think fit that description.
Here are three stocks on the verge of making the magical 100-cent milestone and are poised to head higher.
